On Wednesday, Following Stocks were among the “Top Gainers” of U.S. Stock Market: Cosan, (NYSE:CZZ), Arcos Dorados Holdings, (NYSE:ARCO), Advaxis, (NASDAQ:ADXS), Lumber Liquidators Holdings, (NYSE:LL)
Cosan, (NYSE:CZZ), with shares gained 7.42%, closed at $6.80.
Arcos Dorados Holdings, (NYSE:ARCO), with shares jumped 7.30%, settled at $5.29.
Advaxis, (NASDAQ:ADXS), with shares climbed 7.27%, and closed at $15.49, hitting new 52-week high of $15.55.
Lumber Liquidators Holdings, (NYSE:LL), gained 7.24%, and closed at $33.01.
Latest NEWS regarding these Stocks are depicted underneath:
Cosan Ltd. (NYSE:CZZ)
Cosan Ltd. (CZZ), has price to sale ratio of 0.65, however, price to book ratio is 0.98. With recent incline, the year-to-date (YTD) performance reflected a -12.26% decline below last year. During the past month the stocks lose -5.16%, bringing three-month performance to -12.71% and six-month performance to -35.85%. The mean recommendation of analysts for this stock is 1.70. (where 1=Buy, 5=Sale).
Cosan Limited, together with its auxiliaries, engages in sugar and ethanol, fuel, logistics services, lubricants, and piped natural gas businesses primarily in Brazil, rest of South America, Europe, the Middle East, Asia, and North America.
Arcos Dorados Holdings Inc. Cla (NYSE:ARCO)
Formerly on March 17, Arcos Dorados Holdings Inc. Cla (ARCO), stated unaudited results for the fourth quarter and audited results for the full year ended December 31, 2014.
Fourth Quarter 2014 Key Results:
- Merged proceeds were $913.6 million, a 12.7% decline as compared to the fourth quarter of 2013. On an organic basis and not including Venezuela, merged proceeds grew 11.1%.
- Systemwide comparable sales raised by 15.4% year-over-year.
- As stated General and Administrative expenses (G&A) as a percentage of proceeds declined by 44 basis points as compared to the same period last year.
- Adjusted EBITDA was $93.3 million, or 20.9% lower year-over-year. Organic Adjusted EBITDA not including Venezuela, reduced by 4.6% as compared to the preceding year quarter.
- Stated net revenue of $10.0 million, contrast to net revenue of $32.1 million in the year-ago period, mainly due to lower operating results and higher foreign exchange losses.
Full Year 2014 Key Results:
- Merged proceeds were $3.7 billion in 2014, a 9.5% decline as compared to 2013. On an organic basis and not including Venezuela, merged proceeds grew 9.6% in the year.
- Systemwide comparable sales raised by 10.0% year-over-year.
- As stated G&A as a percentage of proceeds declined by 43 basis points as compared to 2013.
- Adjusted EBITDA was $251.7 million, or 26.9% lower year-over-year. Organic Adjusted EBITDA not including Venezuela, raised by 0.6% as compared to the preceding year.
- Stated a net loss of $109.3 million, contrast to net revenue of $53.9 million one year ago, mostly the result of the influences from the transitions to SICAD and SICAD II in Venezuela.
- Capital expenditures for the year totaled $169.8 million, which comprised of 82 new restaurant openings and brought the overall restaurant count to 2,121 at year end.
Arcos Dorados is the world’s largest McDonald’s franchisee in terms of systemwide sales and number of restaurants, operating the largest quick service restaurant (“QSR”) chain in Latin America and the Caribbean.
Advaxis, Inc. (NASDAQ:ADXS)
Formerly on March 19, Advaxis, Inc. (ADXS), declared that the first patient was dosed in a Phase 1/2 clinical trial evaluating higher doses and repeat cycles of ADXS-HPV (ADXS11-001), an investigational Lm-LLO immunotherapy, for the treatment of patients with recurrent cervical cancer.
The interventional, open-label, non-randomized dose-escalation study is designed to evaluate the safety, efficacy and immunological effect of ADXS-HPV administered at doses up to 1 x 1010 colony forming units (CFU) in repeat cycles of treatment in about 25 women with cervical cancer whose disease recurred after receiving one preceding cytotoxic treatment regimen. Preclinical evidence with ADXS-HPV supports the potential for a dose-response relationship and warrants investigation beyond the 1 x 109 CFU 3 dose/cycle administration that has been studied with manageable safety to date. Further information about the Phase 1/2 study can be found on ClinicalTrials.gov, using Identifier NCT02164461.
Sharad Ghamande, M.D., Director of Gynecology Oncology Cancer Center, Georgia Reagents University Cancer Center, and principal investigator for the study, commented, “Recurrent cervical cancer is a fatal disease that has been resistant to most treatments, with a one-year survival rate of about 10-15%. Survival data from the Phase 2 studies with a single cycle of ADXS-HPV at a lower dose in this patient population was encouraging, and we hope that we can improve clinical outcomes by using a higher dose and repeat cycles of treatment.”
Advaxis, Inc., a clinical stage biotechnology corporation, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States.
Lumber Liquidators Holdings, Inc. (NYSE:LL)
Lumber Liquidators Holdings, Inc. (LL), holds the market capitalization of $1.80B. For the last twelve months, the stock was able to keep return on equity at 9.80%, while return on assets at 2.00%, in response to its return on investment at 6.40%. Its 20-day moving average gained 3.14%, below 50-day moving average of -4.65%, below 200-day moving average of -30.75% from the latest market price of $6.80. The mean recommendation of analysts for this stock is 1.70.(where 1=Buy, 5=Sale).
Cosan Limited, together with its subsidiaries, engages in sugar and ethanol, fuel, logistics services, lubricants, and piped natural gas businesses primarily in Brazil, rest of South America, Europe, the Middle East, Asia, and North America. The company’s Razen Energia segment produces and markets various products derived from sugar cane, counting raw sugar, and anhydrous and hydrated ethanol.
Lumber Liquidators Holdings, Inc., together with its auxiliaries, operates as a multi-channel specialty retailer of hardwood flooring, and hardwood flooring enhancements and accessories. It primarily offers solid and engineered hardwood products; laminate floorings; bamboo floor products, cork floorings, and vinyl plank flooring; wood flooring moldings; butcher block kitchen countertops, and staircase treads and risers; and accessories, such as sealers, adhesives, and underlayments, in addition to flooring tools and floor cleaning supplies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
